Who we are

Each member of our team has a proven track record in deploying industrial manufacturing processes

Managing Partners

Partners

Cameron Begley

Bachelor of Chemical Engineering (Hons), MBA (Exec)

Senior level management, business development and commercial executive with extensive experience in technology commercialization across the public and private sectors.
Proven background in executing technical and commercial operations in local and globally networked teams, delivering sustainable and profitable technologies to industry.


https://www.spiegare.com.au/

Paul Hanselmann

Dr. rer. nat. in Organic Chemistry, ETH Zurich, Switzerland

> 30 years of senior management experience in R&D in the CDMO services industry.
Wide experience in drug substance development, agrochemical development, polymer chemistry, basic chemicals and continuous manufacturing.
Expert in data (text) mining & Scientific collaboration with third parties. Invited lector at the University of Wuhan for teaching industrial chemistry.

Author of 10 scientific publications and inventor of 40 patents.

David Laffan

PhD in Organic Chemistry, University of Cambridge, Fellow of the Royal Society of Chemistry

>25 years of Senior Management experience in the Pharmaceutical and Life Science industries. 
Expertise in leading all aspects of drug substance development, from compound and form selection through to marketing submissions, including more than five drug launches, and life cycle improvements.

Extensive experience in small molecule and TIDES drugs across therapeutic areas and includes products with breakthrough status.

Author of 12 scientific publications and inventor of 11 patents. 

Diego Schmidhalter

Dr. rer. nat. in Biology, University of Fribourg



30 years of business and senior management experience, in leading a biopharma R&D business, manufacturing operations and global innovation in the CDMO services industry, expert for single-use technologies.
Proven track record in process development, technology transfer, in plant design and development of state-of-the-art manufacturing concepts for industrial production of biopharmaceutical and biochemical products up to commercial scale (50m3).

Book editor and author of 17 scientific publications and 2 patents.

Contact